Literature DB >> 16181677

Central nervous system manifestations of Mycoplasma pneumoniae infections.

S Tsiodras1, I Kelesidis, T Kelesidis, E Stamboulis, H Giamarellou.   

Abstract

Mycoplasma pneumoniae infection is associated with several manifestations from the central nervous system (CNS) such as encephalitis, aseptic meningitis, acute transverse myelitis, stroke, and polyradiculopathy. In the current paper epidemiologic, clinical, laboratory and treatment data on these manifestations are reviewed. The M. pneumoniae induced immune dysregulation and its contributing role in the pathogenesis of neurological insult is discussed. The recent introduction in clinical practice of newer molecular diagnostic techniques has helped in establishing a firmer association between M. pneumoniae infection and CNS disease especially encephalitis. Clinicians should be aware of the potential association between M. pneumoniae infection and several CNS manifestations. The role of various anti-microbial or immunomodulating therapies in treating such manifestations should be further explored.

Entities:  

Mesh:

Year:  2005        PMID: 16181677     DOI: 10.1016/j.jinf.2005.07.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  45 in total

1.  Comparison of commercial and in-house real-time PCR assays used for detection of Mycoplasma pneumoniae.

Authors:  Roger Dumke; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

2.  Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation.

Authors:  Jonas M Winchell; Kathleen A Thurman; Stephanie L Mitchell; W Lanier Thacker; Barry S Fields
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

3.  Mycoplasma pneumonia as a cause of neuromyelitis optica?

Authors:  Andreas Gebhardt; Robert Buehler; Roland Wiest; Friedemann Tewald; Johann Sellner; Sebastian Humpert; Heinrich P Mattle; Alain Kaelin-Lang
Journal:  J Neurol       Date:  2008-06-23       Impact factor: 4.849

4.  Meningitis associated with bilateral optic papillitis following Mycoplasma pneumoniae infection.

Authors:  Zhen-Ni Guo; Hong-Liang Zhang; Jing Bai; Jiang Wu; Yi Yang
Journal:  Neurol Sci       Date:  2011-07-06       Impact factor: 3.307

5.  Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study.

Authors:  Alvaro J Benitez; Maureen H Diaz; Bernard J Wolff; Guillermo Pimentel; M Kariuki Njenga; Alejandra Estevez; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

6.  Implication of glycerol and phospholipid transporters in Mycoplasma pneumoniae growth and virulence.

Authors:  Stephanie Großhennig; Sebastian R Schmidl; G Schmeisky; Julia Busse; Jörg Stülke
Journal:  Infect Immun       Date:  2013-01-07       Impact factor: 3.441

7.  Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages.

Authors:  Pitchaimani Kandasamy; Simona Zarini; Edward D Chan; Christina C Leslie; Robert C Murphy; Dennis R Voelker
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

8.  Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases.

Authors:  Benedikt Maria Huber; Susi Strozzi; Maja Steinlin; Christoph Aebi; Simon Fluri
Journal:  Eur J Pediatr       Date:  2009-09-24       Impact factor: 3.183

9.  Mycoplasma pneumonia: Clinical features and management.

Authors:  Surender Kashyap; Malay Sarkar
Journal:  Lung India       Date:  2010-04

Review 10.  Nanotechnology, nanotoxicology, and neuroscience.

Authors:  Won Hyuk Suh; Kenneth S Suslick; Galen D Stucky; Yoo-Hun Suh
Journal:  Prog Neurobiol       Date:  2008-09-24       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.